Trial Profile
Effects of Iloprost on Pulmonary Hemodynamics and Oxygenation in Patients of Chronic Obstructive Pulmonary Disease During One-lung Ventilation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Mar 2020
Price :
$35
*
At a glance
- Drugs Iloprost (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 09 Mar 2020 Primary endpoint (PaO2 /FiO2 ratio during one-lung ventilation) has been met, as per Results published in the Anesthesia and Analgesia
- 09 Mar 2020 Results published in the Anesthesia and Analgesia
- 19 Jun 2016 Status changed from recruiting to completed.